We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDSB
8276
Fifth District Bancorp
FDSB
$94.7M
$10.4K ﹤0.01%
825
-1,486
-64% -$17.6K
SCIO icon
8277
First Trust Structured Credit Income Opportunities ETF
SCIO
$521M
$10.4K ﹤0.01%
517
+500
+2,941% +$10.2K
DFSU
8278
Dimensional US Sustainability Core 1 ETF
DFSU
$2.36B
$10.4K ﹤0.01%
+274
New +$10.5K
SGMA
8279
DELISTED
Sigmatron International
SGMA
$10.4K ﹤0.01%
+5,834
New +$15.2K
SYRS
8280
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$10.4K ﹤0.01%
45,050
+28,322
+169% +$34K
FTIF icon
8281
First Trust Bloomberg Inflation Sensitive Equity ETF
FTIF
$5.79M
$10.4K ﹤0.01%
483
BCDA icon
8282
BioCardia
BCDA
$13.9M
$10.4K ﹤0.01%
+4,750
New +$11.1K
IOPP icon
8283
Simplify Tara India Opportunities ETF
IOPP
$7.41M
$10.3K ﹤0.01%
+386
New +$11.3K
HYDR icon
8284
Global X Hydrogen ETF
HYDR
$101M
$10.3K ﹤0.01%
448
-1,067
-70% -$24.9K
KEUA
8285
DELISTED
KraneShares European Carbon Allowance Strategy ETF
KEUA
$10.3K ﹤0.01%
473
+245
+107% +$5.46K
USBC
8286
USBC Inc
USBC
$140M
$10.2K ﹤0.01%
1,488
+1,371
+1,172% +$12.1K
ION icon
8287
ProShares S&P Global Core Battery Metals ETF
ION
$12.9M
$10.2K ﹤0.01%
+403
New +$11.5K
NEUP
8288
Neuphoria Therapeutics
NEUP
$20.7M
$10.2K ﹤0.01%
+2,978
New +$10.5K
MYLD icon
8289
Cambria Micro and SmallCap Shareholder Yield ETF
MYLD
$34.4M
$10.2K ﹤0.01%
+393
New +$10.6K
BH.A icon
8290
Biglari Holdings Class A
BH.A
$1.21B
$10.2K ﹤0.01%
8
-1
-11% -$1.06K
PROV icon
8291
Provident Financial
PROV
$113M
$10.2K ﹤0.01%
641
-23
-3% -$360
KRKR
8292
36Kr Holdings
KRKR
$6.24M
$10.2K ﹤0.01%
3,233
-1,411
-30% -$5.51K
CARM
8293
DELISTED
Carisma Therapeutics
CARM
$10.2K ﹤0.01%
24,301
+24,083
+11,047% +$19.8K
SMX icon
8294
SMX (Security Matters) Plc
SMX
$17.1M
0
LPL icon
8295
LG Display
LPL
$3.44B
$10.1K ﹤0.01%
3,299
+1,380
+72% +$4.86K
RHE
8296
DELISTED
Regional Health Properties, Inc.
RHE
$10.1K ﹤0.01%
6,476
+5,060
+357% +$8.64K
CLDI icon
8297
Calidi Biotherapeutics
CLDI
$3.99M
$10.1K ﹤0.01%
46
+41
+820% +$12.3K
NNAVW
8298
DELISTED
NextNav Inc Warrant
NNAVW
$10.1K ﹤0.01%
1,759
-976
-36% -$4.99K
JCPB icon
8299
JPMorgan Core Plus Bond ETF
JCPB
$14.1B
$10.1K ﹤0.01%
+219
New +$10.3K
NFLP icon
8300
Kurv Yield Premium Strategy Netflix (NFLX) ETF
NFLP
$4.9M
$10.1K ﹤0.01%
+294
New +$10.1K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.